Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 865.50
+5.60 (0.65%)
Jul 31, 2026, 3:29 PM IST
Supriya Lifescience Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 2,091 | 1,880 | 1,191 | 898.57 | 1,518 |
Depreciation & Amortization | 284.09 | 200.84 | 154.45 | 114.52 | 97.52 |
Other Amortization | - | 3.6 | 3.66 | 3.63 | 3.66 |
Loss (Gain) From Sale of Assets | 0.09 | 0.06 | - | 1.11 | - |
Other Operating Activities | -42.7 | -53.72 | -44.76 | -43.63 | -87.74 |
Change in Accounts Receivable | -850.85 | -226.79 | -270.19 | 305.19 | -416.83 |
Change in Inventory | -412.48 | -331 | 305.21 | -234.58 | -198.32 |
Change in Accounts Payable | 363.01 | 149.76 | -46.59 | 152.56 | -20.5 |
Change in Other Net Operating Assets | 425.33 | 24.42 | -159.85 | -561.32 | -407.88 |
Operating Cash Flow | 1,858 | 1,647 | 1,133 | 636.05 | 488.01 |
Operating Cash Flow Growth | 12.81% | 45.34% | 78.14% | 30.34% | -35.69% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -1,522 | -1,624 | -1,457 | -1,079 | -599.04 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.82 |
Investment in Securities | -352.82 | 5.56 | -385 | -252.43 | - |
Other Investing Activities | 113.43 | 95.76 | 105.81 | 94.99 | - |
Investing Cash Flow | -1,762 | -1,522 | -1,736 | -1,237 | -598.22 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 0.55 | - | - | - | - |
Short-Term Debt Repaid | - | - | -166.25 | -46.7 | -486.07 |
Long-Term Debt Repaid | - | -1.08 | -3.54 | -2.78 | -7.63 |
Total Debt Repaid | - | -1.08 | -169.79 | -49.48 | -493.7 |
Net Debt Issued (Repaid) | 0.55 | -1.08 | -169.79 | -49.48 | -493.7 |
Issuance of Common Stock | - | - | - | - | 2,000 |
Common Dividends Paid | -80.48 | -64.39 | -48.29 | -48.29 | -43.91 |
Other Financing Activities | -18.89 | -16.86 | -5.51 | -4.99 | 34.13 |
Financing Cash Flow | -98.82 | -82.33 | -223.59 | -102.76 | 1,497 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | 0.01 | -0.01 | - |
Net Cash Flow | -2.87 | 41.98 | -826.25 | -703.26 | 1,386 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 335.34 | 22.99 | -323.48 | -443.05 | -111.03 |
Free Cash Flow Growth | 1358.63% | - | - | - | - |
Free Cash Flow Margin | 4.05% | 0.33% | -5.67% | -9.61% | -2.10% |
Free Cash Flow Per Share | 4.17 | 0.29 | -4.02 | -5.50 | -1.38 |
Levered Free Cash Flow | -155.76 | -215.62 | -498.56 | -582.63 | -165.84 |
Unlevered Free Cash Flow | -143.96 | -212.61 | -476.12 | -563.35 | -139.6 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 18.89 | 16.86 | 5.51 | 4.99 | 36.58 |
Cash Income Tax Paid | 613.99 | 591.79 | 376.45 | 306.8 | 609.62 |
Change in Working Capital | -474.99 | -383.61 | -171.42 | -338.15 | -1,044 |